Symptoms of rheumatoid arthritis, such as pain and fatigue, are difficult for others to understand, so patients with rheumatoid arthritis tend to keep to themselves and not ask for help.

Trial assesses proprietary new device that delivers doses of electricity to treat rheumatoid arthritis; builds on first-in-human data SetPoint Medical, a clinical-stage biomedical technology ...

SetPoint Medical has submitted a premarket approval (PMA) application to the US Food and Drug Administration (FDA) for a neuroimmune modulation device aimed at treating rheumatoid arthritis (RA ...

Study to determine which treatments best for which inflammatory arthritis patients should result in patients being better ...

so they created a device that could stimulate these fibres and regulate TNF production. The first trial of this new implant took place in Europe in patients with severe rheumatoid arthritis ...

There is a bidirectional association between rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD), according to a review published online Dec. 1 in Frontiers in Immunology.

Adalimumab trough levels of 4.0 mg/L or higher among patients with RA were linked to greater treatment response and achievement of remission.